he molecular mechanism of action and therapeutic potential of a drug candidate that targets the protein translation machinery inside melanoma cells Sokoloff Family-MRA Established Investigator Award, 2017-2020 Ze'ev Ronai, Technion Israel Institute of Technology Cell of origin as a driver of heterogeneity in melanoma: Aims to better understand